| Dr Zachary G Pena, MD | |
|
10151 Se Sunnyside Rd Ste 240, Clackamas, OR 97015-5774 | |
| (503) 962-1840 | |
| Not Available |
| Full Name | Dr Zachary G Pena |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 11 Years |
| Location | 10151 Se Sunnyside Rd Ste 240, Clackamas, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538592399 | NPI | - | NPPES |
| 500673056 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD182288 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Portland Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 0648183608 | 1328 |
News Archive
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that United Healthcare changed its lumbar spinal fusion policy to include coverage for the eXtreme Lateral Interbody Fusion, or XLIF procedure, published on February 26, 2010, a reversal from its previous policy that labeled XLIF as unproven.
Preventing the cut in Medicare payments to doctors is estimated to cost more than $20 billion next year. It is considered a near certainty that Congress will address it because of the clout that Medicare and doctors have with lawmakers. Within minutes of Monday's announcement that the supercommittee had failed, the American Medical Association was warning that the 27 percent cut would "force many physicians to limit the number of Medicare and TRICARE patients they can care for in their practices."
Sustainable, comprehensive and problem-based training to prevent child obesity will now be possible thanks to a $4.5 million, five-year grant from the U.S. Department of Agriculture.
AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease and end-stage renal disease.
Royal Philips Electronics today announced the enhanced iE33 xMATRIX cardiac ultrasound system featuring a new ergonomic solution for more efficient adult echocardiograms, the X5-1 transducer. With this enhanced technology, Philips continues its tradition of simplified, patient-focused healthcare solutions by providing a more complete imaging solution.
› Verified 3 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that United Healthcare changed its lumbar spinal fusion policy to include coverage for the eXtreme Lateral Interbody Fusion, or XLIF procedure, published on February 26, 2010, a reversal from its previous policy that labeled XLIF as unproven.
Preventing the cut in Medicare payments to doctors is estimated to cost more than $20 billion next year. It is considered a near certainty that Congress will address it because of the clout that Medicare and doctors have with lawmakers. Within minutes of Monday's announcement that the supercommittee had failed, the American Medical Association was warning that the 27 percent cut would "force many physicians to limit the number of Medicare and TRICARE patients they can care for in their practices."
Sustainable, comprehensive and problem-based training to prevent child obesity will now be possible thanks to a $4.5 million, five-year grant from the U.S. Department of Agriculture.
AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease and end-stage renal disease.
Royal Philips Electronics today announced the enhanced iE33 xMATRIX cardiac ultrasound system featuring a new ergonomic solution for more efficient adult echocardiograms, the X5-1 transducer. With this enhanced technology, Philips continues its tradition of simplified, patient-focused healthcare solutions by providing a more complete imaging solution.
› Verified 3 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003991845 PECOS PAC ID: 5395656284 Enrollment ID: O20031113000626 |
News Archive
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that United Healthcare changed its lumbar spinal fusion policy to include coverage for the eXtreme Lateral Interbody Fusion, or XLIF procedure, published on February 26, 2010, a reversal from its previous policy that labeled XLIF as unproven.
Preventing the cut in Medicare payments to doctors is estimated to cost more than $20 billion next year. It is considered a near certainty that Congress will address it because of the clout that Medicare and doctors have with lawmakers. Within minutes of Monday's announcement that the supercommittee had failed, the American Medical Association was warning that the 27 percent cut would "force many physicians to limit the number of Medicare and TRICARE patients they can care for in their practices."
Sustainable, comprehensive and problem-based training to prevent child obesity will now be possible thanks to a $4.5 million, five-year grant from the U.S. Department of Agriculture.
AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease and end-stage renal disease.
Royal Philips Electronics today announced the enhanced iE33 xMATRIX cardiac ultrasound system featuring a new ergonomic solution for more efficient adult echocardiograms, the X5-1 transducer. With this enhanced technology, Philips continues its tradition of simplified, patient-focused healthcare solutions by providing a more complete imaging solution.
› Verified 3 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366536963 PECOS PAC ID: 6103728753 Enrollment ID: O20040123000371 |
News Archive
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that United Healthcare changed its lumbar spinal fusion policy to include coverage for the eXtreme Lateral Interbody Fusion, or XLIF procedure, published on February 26, 2010, a reversal from its previous policy that labeled XLIF as unproven.
Preventing the cut in Medicare payments to doctors is estimated to cost more than $20 billion next year. It is considered a near certainty that Congress will address it because of the clout that Medicare and doctors have with lawmakers. Within minutes of Monday's announcement that the supercommittee had failed, the American Medical Association was warning that the 27 percent cut would "force many physicians to limit the number of Medicare and TRICARE patients they can care for in their practices."
Sustainable, comprehensive and problem-based training to prevent child obesity will now be possible thanks to a $4.5 million, five-year grant from the U.S. Department of Agriculture.
AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease and end-stage renal disease.
Royal Philips Electronics today announced the enhanced iE33 xMATRIX cardiac ultrasound system featuring a new ergonomic solution for more efficient adult echocardiograms, the X5-1 transducer. With this enhanced technology, Philips continues its tradition of simplified, patient-focused healthcare solutions by providing a more complete imaging solution.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zachary G Pena, MD Po Box 3158, Portland, OR 97208-3158 Ph: () - | Dr Zachary G Pena, MD 10151 Se Sunnyside Rd Ste 240, Clackamas, OR 97015-5774 Ph: (503) 962-1840 |
News Archive
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that United Healthcare changed its lumbar spinal fusion policy to include coverage for the eXtreme Lateral Interbody Fusion, or XLIF procedure, published on February 26, 2010, a reversal from its previous policy that labeled XLIF as unproven.
Preventing the cut in Medicare payments to doctors is estimated to cost more than $20 billion next year. It is considered a near certainty that Congress will address it because of the clout that Medicare and doctors have with lawmakers. Within minutes of Monday's announcement that the supercommittee had failed, the American Medical Association was warning that the 27 percent cut would "force many physicians to limit the number of Medicare and TRICARE patients they can care for in their practices."
Sustainable, comprehensive and problem-based training to prevent child obesity will now be possible thanks to a $4.5 million, five-year grant from the U.S. Department of Agriculture.
AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease and end-stage renal disease.
Royal Philips Electronics today announced the enhanced iE33 xMATRIX cardiac ultrasound system featuring a new ergonomic solution for more efficient adult echocardiograms, the X5-1 transducer. With this enhanced technology, Philips continues its tradition of simplified, patient-focused healthcare solutions by providing a more complete imaging solution.
› Verified 3 days ago
Jo M Martin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9900 Se Sunnyside Rd, Nw Permanente Pc, Physicians And Surgeons, Clackamas, OR 97015 Phone: 503-571-3332 | |
Peter E Goodkin, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 9775 Se Sunnyside Road, Suite 500, Clackamas, OR 97015 Phone: 503-654-7546 Fax: 503-786-3542 | |
Matthew G Basco, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9800 Se Sunnyside Rd, Mt Scott Medical Office, Clackamas, OR 97015 Phone: 503-571-8490 | |
Travis James Widman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9900 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-571-3332 | |
Mary Clare Bohnett, MD Dermatology Medicare: Medicare Enrolled Practice Location: 10151 Se Sunnyside Rd Ste 240, Clackamas, OR 97015 Phone: 503-962-1840 | |
Kenneth Myungdei Kang, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9900 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-571-0000 |